ATC level alterations
Previous ATC code | ATC level name | New ATC code |
---|---|---|
L01XY02 | pertuzumab and trastuzumab | L01FY01 |
L01XY03 | nivolumab and relatlimab | L01FY02 |
L04AA02 | muromonab-CD3 | L04AG01 |
L04AA10 | sirolimus | L04AH01 |
L04AA13 | leflunomide | L04AK01 |
L04AA18 | everolimus | L04AH02 |
L04AA21 | efalizumab | L04AG02 |
L04AA23 | natalizumab | L04AG03 |
L04AA25 | eculizumab | L04AJ01 |
L04AA26 | belimumab | L04AG04 |
L04AA27 | fingolimod | L04AE01 |
L04AA29 | tofacitinib | L04AF01 |
L04AA31 | teriflunomide | L04AK02 |
L04AA33 | vedolizumab | L04AG05 |
L04AA34 | alemtuzumab | L04AG06 |
L04AA35 | begelomab | L04AG07 |
L04AA36 | ocrelizumab | L04AG08 |
L04AA37 | baricitinib | L04AF02 |
L04AA38 | ozanimod | L04AE02 |
L04AA39 | emapalumab | L04AG09 |
L04AA42 | siponimod | L04AE03 |
L04AA43 | ravulizumab | L04AJ02 |
L04AA44 | upadacitinib | L04AF03 |
L04AA45 | filgotinib | L04AF04 |
L04AA46 | itacitinib | L04AF05 |
L04AA47 | inebilizumab | L04AG10 |
L04AA49 | peficitinib | L04AF06 |
L04AA50 | ponesimod | L04AE04 |
L04AA51 | anifrolumab | L04AG11 |
L04AA52 | ofatumumab | L04AG12 |
L04AA53 | teprotumumab | L04AG13 |
L04AA54 | pegcetacoplan | L04AJ03 |
L04AA55 | sutimlimab | L04AJ04 |
L04AA56 | deucravacitinib | L04AF07 |
L04AA57 | ublituximab | L04AG14 |
L04AA59 | avacopan | L04AJ05 |
N05CM19 | suvorexant | N05CJ01 |
N05CM21 | lemborexant | N05CJ02 |
Last updated: 2023-12-15